Komori
Yuki Gosei Kogyo (4531) · RiskWorsened

Risk of Financial Covenants Under Syndicated Loans and Other Facilities

First written in FY2016. 4 of 9 entries say "Worsened", first in FY2017. Latest entry: FY2026.

9entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseWorsenedFY2017 – FY2018MitigatedFY2019 – FY2022WorsenedFY2024 – FY20262016: 120162017: 120172018: 120182019: 120192020: 120202021: 120212022: 120222023: 020232024: 120242025: 020252026: 12026
Same theme, other companies
Risk of repayment obligations on borrowings due to breach of financial covenantsA theme 163 companies write about · 164 as a headwind · 0 as a tailwind

Yuki Gosei Kogyo moved to the "Worse" side of this theme in 2017, 6 years before the typical company in this theme (2023).

The whole theme swung hardest in 2017: 8 of 54 companies on the "Worse" side.

22 other companies' latest entry also says "Worsened".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 163 companies compared. The sentences above are computed from all 163.
Full recordFilings, disclosures and news, newest first
  1. FY2026WorsenedAnnual report

    「The Company entered into a syndicated loan with its financial institution counterparties, and the balance of borrowings under the agreement at the end of the fiscal year was ¥4,593 million.」

    The syndicated loan balance increased from ¥2,168 million in the previous disclosure to ¥4,593 million. The risk of losing the benefit of time if the financial covenants are breached also continues to be disclosed.
  2. FY2024WorsenedAnnual report

    「The Company entered into a syndicated loan with its financial institution counterparties, and the balance of borrowings under the agreement at the end of the fiscal year was ¥2,168 million.」

    The syndicated loan balance increased from ¥1,393 million in the previous fiscal year to ¥2,168 million. The possibility of losing the benefit of time if the financial covenants are breached continues to be disclosed.
  3. FY2022MitigatedAnnual report

    「The Company entered into a syndicated loan with its financial institution counterparties, and the balance of borrowings under the agreement at the end of the fiscal year was ¥1,393 million.」

    The syndicated loan balance decreased from ¥1,756 million in the previous fiscal year to ¥1,393 million, reducing exposure to the financial covenants. However, the possibility of losing the benefit of time if the covenants are breached continues to be disclosed.
  4. FY2021MitigatedAnnual report

    「The balance of borrowings under the syndicated loan at the end of the fiscal year was ¥1,756 million.」

    The syndicated loan balance decreased from ¥2,118 million in the previous fiscal year to ¥1,756 million, reducing exposure to the financial covenants. However, the possibility of losing the benefit of time if the covenants are breached continues to be disclosed.
  5. FY2020MitigatedAnnual report

    「The balance of borrowings under the syndicated loan at the end of the fiscal year was ¥2,118 million.」

    The syndicated loan balance decreased from ¥2,681 million in the previous fiscal year to ¥2,118 million, reducing exposure to financial covenant risks.
  6. FY2019MitigatedAnnual report

    「The balance of borrowings under the syndicated loan at the end of the fiscal year was ¥2,681 million. In addition to this syndicated loan, the Company has entered into loan commitment line agreements. If the Company breaches the financial covenants under these agreements, it may lose the benefit of time on its borrowings, which could affect its financial position.」

    The syndicated loan balance decreased from ¥3,243 million in the previous fiscal year to ¥2,681 million, reducing exposure to financial covenant risks. However, the risk itself continues to be disclosed.
  7. FY2018WorsenedAnnual report

    「The balance of borrowings under the syndicated loan at the end of the fiscal year was ¥3,243 million. In addition to this syndicated loan, the Company has entered into loan commitment line agreements. If the Company breaches the financial covenants under these agreements, it may lose the benefit of time on its borrowings, which could affect its financial position.」

    The syndicated loan balance increased from ¥2,250 million in the previous fiscal year to ¥3,243 million, expanding exposure to the financial covenants.
  8. FY2017WorsenedAnnual report

    「The balance of borrowings under the syndicated loan in question was ¥2,250 million at the end of the fiscal year. In addition to the syndicated loan in question, the Company has entered into loan commitment line agreements. If it breaches the financial covenants under these agreements, it may lose the benefit of time with respect to its borrowings, which could affect its financial position.」

    The syndicated loan balance increased from ¥1,800 million in the previous period to ¥2,250 million, expanding exposure to the risk of breaching financial covenants.
  9. FY2016First statedAnnual report

    「In addition to the syndicated loan in question, the Company has entered into loan commitment line agreements. If it breaches the financial covenants under these agreements, it may lose the benefit of time with respect to its borrowings, which could affect its financial position.」

    Against the backdrop of a syndicated loan balance of ¥1,800 million and total loan commitment line agreements of ¥1,000 million, the Company indicates the possibility of breaching financial covenants.
Moved together

"Putting Pharmaceutical Intermediates and APIs on a Growth Trajectory" moved the same way as this thread, in the same document, in 5 of its 9 moves.

554332★123456
  1. ★This thread
  2. 1Putting Pharmaceutical Intermediates and APIs on a Growth Trajectory5×
  3. 2Revitalizing and Rebuilding the Amino-Acid Business and Maintaining and Expanding Top Market Share Through Global Expansion5×
  4. 3Dependence on Major Customers4×
  5. 4Improving Profitability Under the FY2016–FY2018 Medium-Term Management Plan3×
  6. 5Balancing Retained Earnings with Stable Dividends3×
  7. 6Performance-Based Compensation Tied to Operating Profit2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Yuki Gosei Kogyo's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risk of Financial Covenants Under Syndicated Loans and Other Facilities | Yuki Gosei Kogyo Co.,Ltd. (4531) | Komori